Beyond Ozempic: One Man's Search for the Right Obesity Treatment

About 1 in 8 adults is currently taking a GLP-1 drug like Ozempic, Wegovy, or Mounjaro for weight loss — but what happens when those medications aren't enough? In this episode, 68-year-old Dana Bichler – currently a Protodeacon and former power lifter – talks about battling obesity for years. Dana tried multiple medications including Ozempic and Mounjaro. These GLP-1 drugs helped but only temporarily. When his obesity led to a life-threatening diagnosis, Dana agreed to an endoscopic sleeve gastrectomy, a minimally invasive surgical procedure that permanently reshapes the stomach. This conversation covers the full spectrum of obesity treatment options — from medications to balloons to endoscopic surgery to major surgery. Key Takeaways: Excess weight can lead to serious medical complications. Dana's brother died of fatty liver disease caused by obesity. The stakes are real. Address obesity before it's too late. Dana waited almost two long. Don't wait for a crisis to be the thing that inspires you to take action. There are multiple options for treating obesity, and if one doesn't work, that is not the end of the road. The least invasive option that works for you is always the right place to start. But if it doesn't work, something else might. Don't lose hope that nothing will. Your doctors will each suggest what THEY know best and feel comfortable with. Your job is to advocate for yourself by knowing all the options available. You can follow and/or get in touch with Archelle by Subscribe to the ArcHealth newsletter⁠⁠⁠⁠ for healthcare tips https://www.archellemd.com/newsletter Subscribe Archelle's insights on Substack for her perspective on the healthcare system: https://substack.com/@archealth